Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 43% Improvement Relative Risk c19hcq.org Ebongue et al. HCQ for COVID-19 LATE TREATMENT Is late treatment with HCQ+AZ beneficial for COVID-19? Retrospective 580 patients in Cameroon Lower mortality with HCQ+AZ (p=0.04) Ebongue et al., Travel Medicine and Infectious D.., doi:10.1016/j.tmaid.2022.102292 Favors HCQ Favors control
Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon
Ebongue et al., Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2022.102292
Ebongue et al., Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala,.., Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2022.102292
Mar 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 580 hospitalized COVID+ patients in Cameroon, showing lower mortality with HCQ+AZ treatment.
risk of death, 43.0% lower, HR 0.57, p = 0.04, treatment 93 of 522 (17.8%), control 36 of 58 (62.1%), NNT 2.3, adjusted per study, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ebongue et al., 18 Mar 2022, retrospective, Cameroon, peer-reviewed, 27 authors, this trial uses multiple treatments in the treatment arm (combined with AZ) - results of individual treatments may vary.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Journal Pre-proof Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon Marie Solange Ndom Ebongue, Daniel Lemogoum, Laurent Mireille EndaleMangamba, Blaise Barche, Christian Eyoum, Styve Hermane Simo Yomi, David Mekolo, Vincent Ngambi, Jacques Doumbe, Christiane Medi Sike, Jerome Boombhi, Grace Ngondi, Christian Biholong, Josephine Kamdem, Liliane Mbenoun, Calixthe Kuaté Tegeu, Armel Djomou, Anastase Dzudie, Felicité Kamdem, Ferdinand Ndom Ntock, Liliane Kuaté Mfeukeu, Eugène Sobngwi, Ida Penda, Richard Njock, Noel Essomba, Jean Cyr Yombi, William Ngatchou PII: S1477-8939(22)00038-2 DOI: https://doi.org/10.1016/j.tmaid.2022.102292 Reference: TMAID 102292 To appear in: Travel Medicine and Infectious Disease Received Date: 1 July 2021 Revised Date: 23 February 2022 Accepted Date: 27 February 2022 Please cite this article as: Ebongue MSN, Lemogoum D, Endale-Mangamba LM, Barche B, Eyoum C, Simo Yomi SH, Mekolo D, Ngambi V, Doumbe J, Sike CM, Boombhi J, Ngondi G, Biholong C, Kamdem J, Mbenoun L, Tegeu CalixtheKuaté, Djomou A, Dzudie A, Kamdem Felicité, Ntock FN, Mfeukeu LilianeKuaté, Sobngwi Eugè, Penda I, Njock R, Essomba N, Yombi JC, Ngatchou W, Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon, Travel Medicine and Infectious Disease (2022), doi: https://doi.org/10.1016/j.tmaid.2022.102292. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2022 Published by Elsevier Ltd. Author’s contribution: Marie Solange Ndom Ebongue (conceptualization, writing, editing, supervision, software) , Daniel Lemogoum (conceptualization, writing, editing, supervision), Laurent Mireille EndaleMangamba (data curation, investigation), Blaise Barche (methodology, software, writing), Christian Eyoum (data curation, investigation), Styve Hermane Simo Yomi (methodology, software, writing), David Mekolo (data curation, investigation), Vincent Ngambi (data curation, investigation), Jacques Doumbe (data curation, investigation), Christiane Medi Sike (data curation, investigation), Jerome Boombhi (reviewing), Grace Ngondi (data curation, investigation), Christian Biholong (data curation, investigation), Josephine Kamdem (data oo f curation, investigation), Liliane Mbenoun (data curation, investigation), Calixthe Kuaté Tegeu (data curation, investigation), Armel Djomou (data curation, investigation), Anastase Dzudie re -p r (reviewing, supervision), Felicité Kamdem (reviewing), Ferdinand Ndom Ntock (reviewing), Liliane Kuaté Mfeukeu (reviewing), Eugène Sobngwi (reviewing) Ida Penda (supervision), Richard Njock (supervision, reviewing), Noel Essomba (supervision, reviewing), Jean Cyr lP Yombi (Reviewing), William Ngatchou (conceptualization, writing, editing, supervision, Jo ur na software). Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala,..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit